
New risk factor for autism and epilepsy identified
The KCC2 K+Cl– co-transporter is critical for the health and maturity of neurons, as it helps to maintain a low concentration of chloride ions in...

AMR: ENABLE selects Mutabilis candidate
Efficacy of beta-lactam antibiotics, which represent 65% of the antibiotics sold throughout the world, is increasingly challenged in Gram-negative...

4SC expands domatinostat combo testing
In an investigator-initiated Phase Ib study (DONIMI) at NKI, 40 patients with melanoma will be enrolled before surgery (neoadjuvant setting) to...

BioVersys receives up to €8m from CARB-X
Privately-owned BioVersys AG, headquartered in Basel, is focusing on research and development of small molecules for multidrug-resistant bacterial...

ImCheck Therapeutics SAS raises €48m
The €48m financing was co-led by Pfizer Ventures, the venture capital arm of Pfizer Inc., and Bpifrance, with the new investors Wellington Partners,...

European circular bioeconomy fund near closing
Hauck & Aufhäuser Fund Services S.A. will act as the Alternative Investment Fund Manager. The ECFB will provide access to equity, debt or...

Polyphor presents AMR breaker
In Nature, Anatol Luther et al. from Polyphor AG and the University of Zurich describe the discovery and characterisation of a new class of...